With funding over the last ten years from the National Center for Advancing Translational Sciences (NCATS), The Drug Discovery Institute has been developing the Microphysiology Systems Database. We have recently launched BioSystics, Inc. , with the Microphysiology Systems Database at its core, the BioSystics Analytics Platform (BioSystics-AP™) captures, analyzes, computationally models and shares data, while developing new knowledge from patient-derived experimental and in vitro model data as a major step to accelerate the path to Patient Digital Twins for precision medicine. The BioSystics team, lead by Dr. D. Lansing Taylor, will introduce the BioSystics-AP™ at the Microphysiology Systems World Summit in New Orleans, May 30-June 3, 2022.